The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current earnings are A$32.53 Billion. In 2023 the company made an earning of A$12.66 Billion, an increase over its 2022 earnings that were of A$11.84 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | A$6.81 B | -46.21% |
2023 | A$12.66 B | 6.93% |
2022 | A$11.84 B | 9.63% |
2021 | A$10.80 B | -17.61% |
2020 | A$13.11 B | -11% |
2019 | A$14.73 B | -4.26% |
2018 | A$15.39 B | -0.54% |
2017 | A$15.47 B | 4.74% |
2016 | A$14.77 B | 14.85% |
2015 | A$12.86 B | 42.85% |
2014 | A$9.00 B | 6.08% |
2013 | A$8.49 B | 5.11% |
2012 | A$8.07 B | 20.7% |
2011 | A$6.69 B | -21.95% |
2010 | A$8.57 B | 2.17% |
2009 | A$8.39 B | -0.88% |
2008 | A$8.46 B | 32.54% |
2007 | A$6.38 B | -1.47% |
2006 | A$6.48 B | -17.42% |
2005 | A$7.85 B | 43.39% |
2004 | A$5.47 B | 7% |
2003 | A$5.11 B | -550.38% |
2002 | -A$1.14 Billion | -141.78% |
2001 | A$2.71 B | 0.72% |
2000 | A$2.70 B | 6.9% |
1999 | A$2.52 B | 27.92% |
1998 | A$1.97 B | 42.14% |
1997 | A$1.38 B | -10.49% |
1996 | A$1.55 B | 21.14% |
1995 | A$1.28 B | 34.99% |
1994 | A$0.94 B | -0.66% |
1993 | A$0.95 B | 5.22% |
1992 | A$0.90 B | 256.55% |
1991 | A$0.25 B | 549.79% |
1990 | A$39.18 M | -157.58% |
1989 | -A$68.06 Million | -410.29% |
1988 | A$21.93 M | -20.47% |
1987 | A$27.57 M | 263.83% |
1986 | A$7.57 M | 487.5% |
1985 | A$1.29 M | -112.7% |
1984 | -A$10.17 Million |